{"transactions":[{"id":1968678,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-06T11:33:42.000Z","date":"2023-03-06","kind":"disposition_to_issuer","acquired":false,"shares":22410,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 7)"},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 7)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."}],"balance_after":0,"derivative":{"exercise_price":5,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":22410},"source":{"system":"sec-edgar","filing":"0001209191-23-016159","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919123016159/doc4.xml","form_type":"4"}},{"id":1968677,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-06T11:33:42.000Z","date":"2023-03-06","kind":"disposition_to_issuer","acquired":false,"shares":40432,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 7)"},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 7)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."}],"balance_after":0,"derivative":{"exercise_price":4.26,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":40432},"source":{"system":"sec-edgar","filing":"0001209191-23-016159","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919123016159/doc4.xml","form_type":"4"}},{"id":1968676,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-06T11:33:42.000Z","date":"2023-03-06","kind":"disposition_to_issuer","acquired":false,"shares":23260,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 7)"},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 7)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."}],"balance_after":0,"derivative":{"exercise_price":9.16,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":23260},"source":{"system":"sec-edgar","filing":"0001209191-23-016159","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919123016159/doc4.xml","form_type":"4"}},{"id":1968675,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-06T11:33:42.000Z","date":"2023-03-06","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 7)"},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 7)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."}],"balance_after":0,"derivative":{"exercise_price":11.02,"expiration_date":"2029-06-12","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-23-016159","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919123016159/doc4.xml","form_type":"4"}},{"id":1968674,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-06T11:33:42.000Z","date":"2023-03-06","kind":"disposition_to_issuer","acquired":false,"shares":15940,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 7)"},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 7)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."}],"balance_after":0,"derivative":{"exercise_price":19.59,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":15940},"source":{"system":"sec-edgar","filing":"0001209191-23-016159","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919123016159/doc4.xml","form_type":"4"}},{"id":1968673,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-06T11:33:42.000Z","date":"2023-03-06","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 7)"},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 7)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."}],"balance_after":0,"derivative":{"exercise_price":13.29,"expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-23-016159","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919123016159/doc4.xml","form_type":"4"}},{"id":1968672,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-06T11:33:42.000Z","date":"2023-03-06","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 7)"},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 7)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."}],"balance_after":0,"derivative":{"exercise_price":12.96,"expiration_date":"2026-06-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-23-016159","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919123016159/doc4.xml","form_type":"4"}},{"id":1968671,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-06T11:33:42.000Z","date":"2023-03-06","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 7)"},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 7)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."}],"balance_after":0,"derivative":{"exercise_price":16.42,"expiration_date":"2025-06-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-23-016159","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919123016159/doc4.xml","form_type":"4"}},{"id":1968670,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-06T11:33:42.000Z","date":"2023-03-06","kind":"other","acquired":false,"shares":44351,"ownership":{"direct":false,"nature":"By Little Eagles, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of January 19, 2023, by and among Concert Pharmaceuticals, Inc. (the \"Issuer\"), Sun Pharmaceutical Industries Ltd. (\"Parent\") and Foliage Merger Sub, Inc., an indirect wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer, effective as of March 6, 2023 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $8.00 in cash (the \"Cash Amount\"), plus one non-tradeable contingent value right (a \"CVR,\" and together with the Cash Amount, the \"Per Share Consideration\"), which represents the right to receive contingent payments of up to $3.50 per Share, in cash, (continued in Footnote 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"in the aggregate, upon the achievement of certain milestones (such applicable payment, each, a \"Milestone Payment\") prior to December 31, 2029, subject to any applicable withholding of taxes and without interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares held by Little Eagles, LLC. The owners of Little Eagles, LLC are the Richard H. Aldrich Irrevocable Trust of 2011 and trusts established for the benefit of Mr. Aldrich's minor children. The trustees of the Richard H. Aldrich Irrevocable Trust of 2011 are Mr. Aldrich's spouse, Nichole A. Aldrich, and Mr. Aldrich's brother, Caleb F. Aldrich. The beneficiaries of the Richard H. Aldrich Irrevocable Trust of 2011 are Mr. Aldrich's minor children. Mr. Aldrich disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-016159","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919123016159/doc4.xml","form_type":"4"}},{"id":1968669,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-06T11:33:42.000Z","date":"2023-03-06","kind":"other","acquired":false,"shares":210526,"ownership":{"direct":false,"nature":"By Richard H. Aldrich 2018 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of January 19, 2023, by and among Concert Pharmaceuticals, Inc. (the \"Issuer\"), Sun Pharmaceutical Industries Ltd. (\"Parent\") and Foliage Merger Sub, Inc., an indirect wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer, effective as of March 6, 2023 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $8.00 in cash (the \"Cash Amount\"), plus one non-tradeable contingent value right (a \"CVR,\" and together with the Cash Amount, the \"Per Share Consideration\"), which represents the right to receive contingent payments of up to $3.50 per Share, in cash, (continued in Footnote 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"in the aggregate, upon the achievement of certain milestones (such applicable payment, each, a \"Milestone Payment\") prior to December 31, 2029, subject to any applicable withholding of taxes and without interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by the Richard H. Aldrich 2018 Revocable Trust. Mr. Aldrich is the sole trustee of the Richard H. Aldrich 2018 Revocable Trust. Mr. Aldrich disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-016159","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919123016159/doc4.xml","form_type":"4"}},{"id":1968668,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-06T11:33:42.000Z","date":"2023-03-06","kind":"disposition_to_issuer","acquired":false,"shares":16400,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This line item represents unvested time-based restricted stock units with respect to the Issuer's common stock (\"RSUs\") held by the Reporting Person. Pursuant to the terms of the Merger Agreement, at the Effective Time, each unvested RSU that was outstanding immediately prior to the Effective Time was cancelled and converted into the right to receive, for each Share underlying such RSU, the Per Share Consideration, subject to withholding of applicable taxes and without interest."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This line item represents unvested time-based restricted stock units with respect to the Issuer's common stock (\"RSUs\") held by the Reporting Person. Pursuant to the terms of the Merger Agreement, at the Effective Time, each unvested RSU that was outstanding immediately prior to the Effective Time was cancelled and converted into the right to receive, for each Share underlying such RSU, the Per Share Consideration, subject to withholding of applicable taxes and without interest."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-016159","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919123016159/doc4.xml","form_type":"4"}},{"id":1968667,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-06T11:33:42.000Z","date":"2023-03-06","kind":"other","acquired":false,"shares":342100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of January 19, 2023, by and among Concert Pharmaceuticals, Inc. (the \"Issuer\"), Sun Pharmaceutical Industries Ltd. (\"Parent\") and Foliage Merger Sub, Inc., an indirect wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer, effective as of March 6, 2023 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $8.00 in cash (the \"Cash Amount\"), plus one non-tradeable contingent value right (a \"CVR,\" and together with the Cash Amount, the \"Per Share Consideration\"), which represents the right to receive contingent payments of up to $3.50 per Share, in cash, (continued in Footnote 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"in the aggregate, upon the achievement of certain milestones (such applicable payment, each, a \"Milestone Payment\") prior to December 31, 2029, subject to any applicable withholding of taxes and without interest."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-016159","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919123016159/doc4.xml","form_type":"4"}},{"id":2233869,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-13T16:12:13.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":22410,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"This option was granted based on Mr. Aldrich's election to receive his annual cash compensation in the form of a stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares underlying this option vest in equal quarterly installments over a one-year period through June 9, 2023, provided that such option shall vest in full on the date that is one business day prior to the date of the Issuer's next annual meeting of stockholders (if earlier than June 9, 2023)."}],"balance_after":22410,"derivative":{"exercise_price":5,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":22410},"source":{"system":"sec-edgar","filing":"0001209191-22-036282","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919122036282/doc4.xml","form_type":"4"}},{"id":2233868,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-13T16:12:13.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":16400,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. These RSUs vest in full on the earlier of (i) June 9, 2023 and (ii) the date that is one business day prior to the date of the Issuer's next annual meeting of stockholders. The amount listed represents the maximum number of shares of Common Stock of the Issuer that may be delivered pursuant to the grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."}],"balance_after":358500,"source":{"system":"sec-edgar","filing":"0001209191-22-036282","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919122036282/doc4.xml","form_type":"4"}},{"id":2241596,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-06T17:11:02.000Z","date":"2022-06-06","kind":"purchase","acquired":true,"shares":210526,"price":4.75,"value":999998.5,"ownership":{"direct":false,"nature":"By Richard H. Aldrich 2018 Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were purchased as part of an underwritten public offering of common stock by the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by the Richard H. Aldrich 2018 Revocable Trust. Mr. Aldrich is the sole trustee of the Richard H. Aldrich 2018 Revocable Trust. Mr. Aldrich disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":210526,"source":{"system":"sec-edgar","filing":"0001209191-22-034578","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919122034578/doc4.xml","form_type":"4"}},{"id":2671575,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-11T08:36:08.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":30182,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"This option was granted based on Mr. Aldrich's election to receive his annual cash compensation in the form of a stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option vest in equal quarterly installments over a one-year period through June 10, 2022, provided that such option shall vest in full on the date that is one business day prior to the date of the Issuer's next annual meeting of stockholders (if earlier than June 10, 2022)."}],"balance_after":30182,"derivative":{"exercise_price":4.26,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":30182},"source":{"system":"sec-edgar","filing":"0001209191-21-039739","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919121039739/doc4.xml","form_type":"4"}},{"id":2671574,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-11T08:36:08.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":10250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option vest in equal quarterly installments over a one-year period through June 10, 2022, provided that such option shall vest in full on the date that is one business day prior to the date of the Issuer's next annual meeting of stockholders (if earlier than June 10, 2022)."}],"balance_after":10250,"derivative":{"exercise_price":4.26,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":10250},"source":{"system":"sec-edgar","filing":"0001209191-21-039739","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919121039739/doc4.xml","form_type":"4"}},{"id":2671573,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-11T08:36:08.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":5125,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. These RSUs vest in full on the earlier of (i) June 10, 2022 and (ii) the date that is one business day prior to the date of the Issuer's next annual meeting of stockholders. The amount listed represents the maximum number of shares of Common Stock of the Issuer that may be delivered pursuant to the grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."}],"balance_after":342100,"source":{"system":"sec-edgar","filing":"0001209191-21-039739","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919121039739/doc4.xml","form_type":"4"}},{"id":3111562,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-12T16:58:26.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":13260,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in equal quarterly installments over a one-year period through June 11, 2021, provided that such option shall vest in full on the date that is one business day prior to the date of the Issuer's next annual meeting of stockholders (if earlier than June 11, 2021)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted to the director based on such director's election to receive annual cash compensation in the form of a stock option."}],"balance_after":13260,"derivative":{"exercise_price":9.16,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":13260},"source":{"system":"sec-edgar","filing":"0001209191-20-036333","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919120036333/doc4.xml","form_type":"4"}},{"id":3111561,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-12T16:58:26.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in equal quarterly installments over a one-year period through June 11, 2021, provided that such option shall vest in full on the date that is one business day prior to the date of the Issuer's next annual meeting of stockholders (if earlier than June 11, 2021)."}],"balance_after":10000,"derivative":{"exercise_price":9.16,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-036333","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919120036333/doc4.xml","form_type":"4"}},{"id":3487547,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (Right to Buy)","published_at":"2019-06-17T21:14:04.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in equal quarterly installments over a one-year period, through and including June 13, 2020."}],"balance_after":10000,"derivative":{"exercise_price":11.02,"expiration_date":"2029-06-12","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-037570","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919119037570/doc4.xml","form_type":"4"}},{"id":3735286,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-11T19:30:33.000Z","date":"2018-12-07","kind":"grant","acquired":true,"shares":755,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $10,625 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $10,625 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018."}],"balance_after":6169,"source":{"system":"sec-edgar","filing":"0001209191-18-062104","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919118062104/doc4.xml","form_type":"4"}},{"id":3763004,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-15T17:21:39.000Z","date":"2018-11-15","kind":"purchase","acquired":true,"shares":40000,"price":11.7817,"value":471268.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The range of prices for the transaction reported on this line was $11.625 to $12.00. The average price was $11.7817. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":336975,"source":{"system":"sec-edgar","filing":"0001209191-18-058781","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919118058781/doc4.xml","form_type":"4"}},{"id":3763003,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-15T17:21:39.000Z","date":"2018-11-15","kind":"purchase","acquired":true,"shares":10000,"price":11.9994,"value":119994.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the transaction reported on this line was $11.97 to $12.00. The average price was $11.9994. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":296975,"source":{"system":"sec-edgar","filing":"0001209191-18-058781","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919118058781/doc4.xml","form_type":"4"}},{"id":3795873,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2018-10-05T18:03:47.000Z","date":"2018-10-03","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a 12 month period: 1/12th on November 3, 2018, after which 1/12th of the total shares vest monthly, subject to continued service through each vesting date."}],"balance_after":7000,"derivative":{"exercise_price":22.65,"expiration_date":"2028-10-02","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001567619-18-003781","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000156761918003781/doc1.xml","form_type":"4"}},{"id":3800857,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-02T18:03:06.000Z","date":"2018-09-28","kind":"grant","acquired":true,"shares":14558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $10,625 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $10,625 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan."}],"balance_after":81220,"source":{"system":"sec-edgar","filing":"0001179110-18-011954","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000117911018011954/edgar.xml","form_type":"4"}},{"id":3871686,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-07-06T18:31:53.000Z","date":"2018-07-04","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in twelve equal monthly installments at the end of each successive month following July 4, 2018."}],"balance_after":12000,"derivative":{"exercise_price":0.9548,"expiration_date":"2028-07-04","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001179110-18-009532","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000117911018009532/edgar.xml","form_type":"4"}},{"id":3874441,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-03T16:35:22.000Z","date":"2018-06-29","kind":"grant","acquired":true,"shares":11709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $10,625 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $10,625 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan."}],"balance_after":66662,"source":{"system":"sec-edgar","filing":"0001179110-18-009346","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000117911018009346/edgar.xml","form_type":"4"}},{"id":3890456,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (Right to Buy)","published_at":"2018-06-18T18:55:35.000Z","date":"2018-06-14","kind":"grant","acquired":true,"shares":5940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in equal quarterly installments over a one-year period, through and including June 14, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were awarded to the director per such director's election to receive annual cash compensation in the form of stock options."}],"balance_after":15940,"derivative":{"exercise_price":19.59,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":5940},"source":{"system":"sec-edgar","filing":"0000899243-18-017069","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000089924318017069/doc4.xml","form_type":"4"}},{"id":3890455,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (Right to Buy)","published_at":"2018-06-18T18:55:35.000Z","date":"2018-06-14","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in equal quarterly installments over a one-year period, through and including June 14, 2019."}],"balance_after":10000,"derivative":{"exercise_price":19.59,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-18-017069","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000089924318017069/doc4.xml","form_type":"4"}},{"id":3972202,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-03T17:25:30.000Z","date":"2018-03-30","kind":"grant","acquired":true,"shares":13101,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $10,625 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $10,625 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan."}],"balance_after":54953,"source":{"system":"sec-edgar","filing":"0001179110-18-005301","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000117911018005301/edgar.xml","form_type":"4"}},{"id":4081614,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-01T16:36:31.000Z","date":"2018-02-01","kind":"sale","acquired":false,"shares":1946,"price":19.99,"value":38900.54,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the holder on December 13, 2017."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Little Bear Associates, Inc., formerly known as RA Capital Associates, Inc. Mr. Aldrich is the sole stockholder of Little Bear Associates, Inc."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-006478","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919118006478/doc4.xml","form_type":"4"}},{"id":4081613,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-01T16:36:31.000Z","date":"2018-01-31","kind":"sale","acquired":false,"shares":300,"price":21.29,"value":6387.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the holder on December 13, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The range of prices for the transaction reported on this line was $21.25 to $21.33. The average weighted price was $21.29. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Little Bear Associates, Inc., formerly known as RA Capital Associates, Inc. Mr. Aldrich is the sole stockholder of Little Bear Associates, Inc."}],"balance_after":1946,"source":{"system":"sec-edgar","filing":"0001209191-18-006478","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919118006478/doc4.xml","form_type":"4"}},{"id":4081612,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-01T16:36:31.000Z","date":"2018-01-31","kind":"sale","acquired":false,"shares":4700,"price":20.78,"value":97666.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the holder on December 13, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The range of prices for the transaction reported on this line was $20.23 to $21.23. The average weighted price was $20.78. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Little Bear Associates, Inc., formerly known as RA Capital Associates, Inc. Mr. Aldrich is the sole stockholder of Little Bear Associates, Inc."}],"balance_after":2246,"source":{"system":"sec-edgar","filing":"0001209191-18-006478","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919118006478/doc4.xml","form_type":"4"}},{"id":4081611,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-01T16:36:31.000Z","date":"2018-01-30","kind":"sale","acquired":false,"shares":5000,"price":21.33,"value":106650.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the holder on December 13, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The range of prices for the transaction reported on this line was $20.80 to $21.65. The average weighted price was $21.33. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Little Bear Associates, Inc., formerly known as RA Capital Associates, Inc. Mr. Aldrich is the sole stockholder of Little Bear Associates, Inc."}],"balance_after":6946,"source":{"system":"sec-edgar","filing":"0001209191-18-006478","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919118006478/doc4.xml","form_type":"4"}},{"id":4086299,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-29T17:43:43.000Z","date":"2018-01-29","kind":"sale","acquired":false,"shares":5000,"price":21.36,"value":106800.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the holder on December 13, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The range of prices for the transaction reported on this line was $20.75 to $21.68. The average weighted price was $21.36. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Little Bear Associates, Inc., formerly known as RA Capital Associates, Inc. Mr. Aldrich is the sole stockholder of Little Bear Associates, Inc."}],"balance_after":11946,"source":{"system":"sec-edgar","filing":"0001209191-18-005919","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919118005919/doc4.xml","form_type":"4"}},{"id":4086298,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-29T17:43:43.000Z","date":"2018-01-26","kind":"sale","acquired":false,"shares":5000,"price":20.46,"value":102300.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the holder on December 13, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The range of prices for the transaction reported on this line was $20.34 to $20.67. The average weighted price was $20.46. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Little Bear Associates, Inc., formerly known as RA Capital Associates, Inc. Mr. Aldrich is the sole stockholder of Little Bear Associates, Inc."}],"balance_after":16946,"source":{"system":"sec-edgar","filing":"0001209191-18-005919","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919118005919/doc4.xml","form_type":"4"}},{"id":4086297,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-29T17:43:43.000Z","date":"2018-01-25","kind":"sale","acquired":false,"shares":3054,"price":20.22,"value":61751.88,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the holder on December 13, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The range of prices for the transaction reported on this line was $20.03 to $20.40. The average weighted price was $20.22. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares held by Little Eagles, LLC. The owners of Little Eagles, LLC are Richard H. Aldrich Irrevocable Trust of 2011 and trusts established for the benefit of Mr. Aldrich's minor children. The trustees of Richard H. Aldrich Irrevocable Trust of 2011 are Mr. Aldrich's spouse, Nichole A. Aldrich, and Mr. Aldrich's brother, Caleb F. Aldrich. The beneficiaries of Richard H. Aldrich Irrevocable Trust of 2011 are Mr. Aldrich's minor children. Mr. Aldrich disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":44351,"source":{"system":"sec-edgar","filing":"0001209191-18-005919","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919118005919/doc4.xml","form_type":"4"}},{"id":4086296,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-29T17:43:43.000Z","date":"2018-01-25","kind":"sale","acquired":false,"shares":5000,"price":20.31,"value":101550.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the holder on December 13, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The range of prices for the transaction reported on this line was $20.01 to $20.74. The average weighted price was $20.31. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Little Bear Associates, Inc., formerly known as RA Capital Associates, Inc. Mr. Aldrich is the sole stockholder of Little Bear Associates, Inc."}],"balance_after":21946,"source":{"system":"sec-edgar","filing":"0001209191-18-005919","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919118005919/doc4.xml","form_type":"4"}},{"id":4090928,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-24T16:43:05.000Z","date":"2018-01-24","kind":"sale","acquired":false,"shares":5000,"price":19.83,"value":99150.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the holder on December 13, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The range of prices for the transaction reported on this line was $19.61 to $20.00. The average weighted price was $19.83. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares held by Little Eagles, LLC. The owners of Little Eagles, LLC are Richard H. Aldrich Irrevocable Trust of 2011 and trusts established for the benefit of Mr. Aldrich's minor children. The trustees of Richard H. Aldrich Irrevocable Trust of 2011 are Mr. Aldrich's spouse, Nichole A. Aldrich, and Mr. Aldrich's brother, Caleb F. Aldrich. The beneficiaries of Richard H. Aldrich Irrevocable Trust of 2011 are Mr. Aldrich's minor children. Mr. Aldrich disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":47405,"source":{"system":"sec-edgar","filing":"0001209191-18-005145","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919118005145/doc4.xml","form_type":"4"}},{"id":4090927,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-24T16:43:05.000Z","date":"2018-01-24","kind":"sale","acquired":false,"shares":5000,"price":19.83,"value":99150.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the holder on December 13, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The range of prices for the transaction reported on this line was $19.61 to $20.00. The average weighted price was $19.83. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Little Bear Associates, Inc., formerly known as RA Capital Associates, Inc. Mr. Aldrich is the sole stockholder of Little Bear Associates, Inc."}],"balance_after":26946,"source":{"system":"sec-edgar","filing":"0001209191-18-005145","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919118005145/doc4.xml","form_type":"4"}},{"id":4090926,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-24T16:43:05.000Z","date":"2018-01-23","kind":"sale","acquired":false,"shares":5000,"price":19.68,"value":98400.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the holder on December 13, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The range of prices for the transaction reported on this line was $19.47 to $19.85. The average weighted price was $19.68. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares held by Little Eagles, LLC. The owners of Little Eagles, LLC are Richard H. Aldrich Irrevocable Trust of 2011 and trusts established for the benefit of Mr. Aldrich's minor children. The trustees of Richard H. Aldrich Irrevocable Trust of 2011 are Mr. Aldrich's spouse, Nichole A. Aldrich, and Mr. Aldrich's brother, Caleb F. Aldrich. The beneficiaries of Richard H. Aldrich Irrevocable Trust of 2011 are Mr. Aldrich's minor children. Mr. Aldrich disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":52405,"source":{"system":"sec-edgar","filing":"0001209191-18-005145","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919118005145/doc4.xml","form_type":"4"}},{"id":4090925,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-24T16:43:05.000Z","date":"2018-01-23","kind":"sale","acquired":false,"shares":5000,"price":19.67,"value":98350.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the holder on December 13, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The range of prices for the transaction reported on this line was $19.47 to $19.85. The average weighted price was $19.67. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Little Bear Associates, Inc., formerly known as RA Capital Associates, Inc. Mr. Aldrich is the sole stockholder of Little Bear Associates, Inc."}],"balance_after":31946,"source":{"system":"sec-edgar","filing":"0001209191-18-005145","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919118005145/doc4.xml","form_type":"4"}},{"id":4090924,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-24T16:43:05.000Z","date":"2018-01-22","kind":"sale","acquired":false,"shares":5000,"price":19.54,"value":97700.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the holder on December 13, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The range of prices for the transaction reported on this line was $19.37 to $19.84. The average weighted price was $19.54. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares held by Little Eagles, LLC. The owners of Little Eagles, LLC are Richard H. Aldrich Irrevocable Trust of 2011 and trusts established for the benefit of Mr. Aldrich's minor children. The trustees of Richard H. Aldrich Irrevocable Trust of 2011 are Mr. Aldrich's spouse, Nichole A. Aldrich, and Mr. Aldrich's brother, Caleb F. Aldrich. The beneficiaries of Richard H. Aldrich Irrevocable Trust of 2011 are Mr. Aldrich's minor children. Mr. Aldrich disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":57405,"source":{"system":"sec-edgar","filing":"0001209191-18-005145","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919118005145/doc4.xml","form_type":"4"}},{"id":4090923,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-24T16:43:05.000Z","date":"2018-01-22","kind":"sale","acquired":false,"shares":5000,"price":19.55,"value":97750.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the holder on December 13, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The range of prices for the transaction reported on this line was $19.41 to $19.82. The average weighted price was $19.55. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Little Bear Associates, Inc., formerly known as RA Capital Associates, Inc. Mr. Aldrich is the sole stockholder of Little Bear Associates, Inc."}],"balance_after":36946,"source":{"system":"sec-edgar","filing":"0001209191-18-005145","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919118005145/doc4.xml","form_type":"4"}},{"id":4094416,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-19T16:34:43.000Z","date":"2018-01-19","kind":"sale","acquired":false,"shares":5000,"price":19.65,"value":98250.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the holder on December 13, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The range of prices for the transaction reported on this line was $19.39 to $19.82. The average weighted price was $19.65. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares held by Little Eagles, LLC. The owners of Little Eagles, LLC are Richard H. Aldrich Irrevocable Trust of 2011 and trusts established for the benefit of Mr. Aldrich's minor children. The trustees of Richard H. Aldrich Irrevocable Trust of 2011 are Mr. Aldrich's spouse, Nichole A. Aldrich, and Mr. Aldrich's brother, Caleb F. Aldrich. The beneficiaries of Richard H. Aldrich Irrevocable Trust of 2011 are Mr. Aldrich's minor children. Mr. Aldrich disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":62405,"source":{"system":"sec-edgar","filing":"0001209191-18-004565","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919118004565/doc4.xml","form_type":"4"}},{"id":4094415,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-19T16:34:43.000Z","date":"2018-01-19","kind":"sale","acquired":false,"shares":5000,"price":19.66,"value":98300.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the holder on December 13, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The range of prices for the transaction reported on this line was $19.49 to $19.82. The average weighted price was $19.66. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Little Bear Associates, Inc., formerly known as RA Capital Associates, Inc. Mr. Aldrich is the sole stockholder of Little Bear Associates, Inc."}],"balance_after":41946,"source":{"system":"sec-edgar","filing":"0001209191-18-004565","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919118004565/doc4.xml","form_type":"4"}},{"id":4094414,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-19T16:34:43.000Z","date":"2018-01-18","kind":"sale","acquired":false,"shares":5000,"price":19.43,"value":97150.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the holder on December 13, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The range of prices for the transaction reported on this line was $19.16 to $19.76. The average weighted price was $19.43. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares held by Little Eagles, LLC. The owners of Little Eagles, LLC are Richard H. Aldrich Irrevocable Trust of 2011 and trusts established for the benefit of Mr. Aldrich's minor children. The trustees of Richard H. Aldrich Irrevocable Trust of 2011 are Mr. Aldrich's spouse, Nichole A. Aldrich, and Mr. Aldrich's brother, Caleb F. Aldrich. The beneficiaries of Richard H. Aldrich Irrevocable Trust of 2011 are Mr. Aldrich's minor children. Mr. Aldrich disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":67405,"source":{"system":"sec-edgar","filing":"0001209191-18-004565","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919118004565/doc4.xml","form_type":"4"}},{"id":4094413,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-19T16:34:43.000Z","date":"2018-01-18","kind":"sale","acquired":false,"shares":5000,"price":19.36,"value":96800.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the holder on December 13, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The range of prices for the transaction reported on this line was $19.14 to $19.77. The average weighted price was $19.36. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Little Bear Associates, Inc., formerly known as RA Capital Associates, Inc. Mr. Aldrich is the sole stockholder of Little Bear Associates, Inc."}],"balance_after":46946,"source":{"system":"sec-edgar","filing":"0001209191-18-004565","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919118004565/doc4.xml","form_type":"4"}},{"id":4094412,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-19T16:34:43.000Z","date":"2018-01-17","kind":"sale","acquired":false,"shares":5000,"price":19.03,"value":95150.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the holder on December 13, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The range of prices for the transaction reported on this line was $19.00 to $19.14. The average weighted price was $19.03. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares held by Little Eagles, LLC. The owners of Little Eagles, LLC are Richard H. Aldrich Irrevocable Trust of 2011 and trusts established for the benefit of Mr. Aldrich's minor children. The trustees of Richard H. Aldrich Irrevocable Trust of 2011 are Mr. Aldrich's spouse, Nichole A. Aldrich, and Mr. Aldrich's brother, Caleb F. Aldrich. The beneficiaries of Richard H. Aldrich Irrevocable Trust of 2011 are Mr. Aldrich's minor children. Mr. Aldrich disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":72405,"source":{"system":"sec-edgar","filing":"0001209191-18-004565","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919118004565/doc4.xml","form_type":"4"}},{"id":4094411,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-19T16:34:43.000Z","date":"2018-01-17","kind":"sale","acquired":false,"shares":5000,"price":18.95,"value":94750.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the holder on December 13, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The range of prices for the transaction reported on this line was $18.77 to $19.07. The average weighted price was $18.95. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Little Bear Associates, Inc., formerly known as RA Capital Associates, Inc. Mr. Aldrich is the sole stockholder of Little Bear Associates, Inc."}],"balance_after":51946,"source":{"system":"sec-edgar","filing":"0001209191-18-004565","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919118004565/doc4.xml","form_type":"4"}},{"id":4095935,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2018-01-18T16:26:34.000Z","date":"2018-01-16","kind":"exercise","acquired":false,"shares":5309,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.88,"expiration_date":"2022-11-12","underlying":"Common Stock","underlying_shares":5309},"source":{"system":"sec-edgar","filing":"0001209191-18-004255","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919118004255/doc4.xml","form_type":"4"}},{"id":4095934,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2018-01-18T16:26:34.000Z","date":"2018-01-16","kind":"exercise","acquired":false,"shares":5309,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":3.5,"expiration_date":"2021-11-01","underlying":"Common Stock","underlying_shares":5309},"source":{"system":"sec-edgar","filing":"0001209191-18-004255","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919118004255/doc4.xml","form_type":"4"}},{"id":4095933,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2018-01-18T16:26:34.000Z","date":"2018-01-16","kind":"exercise","acquired":false,"shares":5309,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":3.79,"expiration_date":"2020-12-03","underlying":"Common Stock","underlying_shares":5309},"source":{"system":"sec-edgar","filing":"0001209191-18-004255","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919118004255/doc4.xml","form_type":"4"}},{"id":4095932,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2018-01-18T16:26:34.000Z","date":"2018-01-16","kind":"exercise","acquired":false,"shares":5309,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":4.41,"expiration_date":"2019-12-10","underlying":"Common Stock","underlying_shares":5309},"source":{"system":"sec-edgar","filing":"0001209191-18-004255","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919118004255/doc4.xml","form_type":"4"}},{"id":4095931,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-18T16:26:34.000Z","date":"2018-01-16","kind":"sale","acquired":false,"shares":5000,"price":19.26,"value":96300.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the holder on December 13, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The range of prices for the transaction reported on this line was $19.00 to $19.42. The average weighted price was $19.26. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares held by Little Eagles, LLC. The owners of Little Eagles, LLC are Richard H. Aldrich Irrevocable Trust of 2011 and trusts established for the benefit of Mr. Aldrich's minor children. The trustees of Richard H. Aldrich Irrevocable Trust of 2011 are Mr. Aldrich's spouse, Nichole A. Aldrich, and Mr. Aldrich's brother, Caleb F. Aldrich. The beneficiaries of Richard H. Aldrich Irrevocable Trust of 2011 are Mr. Aldrich's minor children. Mr. Aldrich disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":77405,"source":{"system":"sec-edgar","filing":"0001209191-18-004255","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919118004255/doc4.xml","form_type":"4"}},{"id":4095930,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-18T16:26:34.000Z","date":"2018-01-16","kind":"sale","acquired":false,"shares":5000,"price":19.27,"value":96350.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the holder on December 13, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The range of prices for the transaction reported on this line was $19.00 to $19.42. The average weighted price was $19.27. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Little Bear Associates, Inc., formerly known as RA Capital Associates, Inc. Mr. Aldrich is the sole stockholder of Little Bear Associates, Inc."}],"balance_after":56946,"source":{"system":"sec-edgar","filing":"0001209191-18-004255","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919118004255/doc4.xml","form_type":"4"}},{"id":4095929,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-18T16:26:34.000Z","date":"2018-01-16","kind":"sale","acquired":false,"shares":21236,"price":19.08,"value":405182.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the holder on December 13, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The range of prices for the transaction reported on this line was $18.91 to $19.70. The average weighted price was $19.08. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":286975,"source":{"system":"sec-edgar","filing":"0001209191-18-004255","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919118004255/doc4.xml","form_type":"4"}},{"id":4095928,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-18T16:26:34.000Z","date":"2018-01-16","kind":"exercise","acquired":true,"shares":5309,"price":2.88,"value":15289.92,"ownership":{"direct":true},"balance_after":308211,"source":{"system":"sec-edgar","filing":"0001209191-18-004255","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919118004255/doc4.xml","form_type":"4"}},{"id":4095927,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-18T16:26:34.000Z","date":"2018-01-16","kind":"exercise","acquired":true,"shares":5309,"price":3.5,"value":18581.5,"ownership":{"direct":true},"balance_after":302902,"source":{"system":"sec-edgar","filing":"0001209191-18-004255","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919118004255/doc4.xml","form_type":"4"}},{"id":4095926,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-18T16:26:34.000Z","date":"2018-01-16","kind":"exercise","acquired":true,"shares":5309,"price":3.79,"value":20121.11,"ownership":{"direct":true},"balance_after":297593,"source":{"system":"sec-edgar","filing":"0001209191-18-004255","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919118004255/doc4.xml","form_type":"4"}},{"id":4095925,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-18T16:26:34.000Z","date":"2018-01-16","kind":"exercise","acquired":true,"shares":5309,"price":4.41,"value":23412.69,"ownership":{"direct":true},"balance_after":292284,"source":{"system":"sec-edgar","filing":"0001209191-18-004255","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919118004255/doc4.xml","form_type":"4"}},{"id":4110945,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-03T20:34:07.000Z","date":"2017-12-29","kind":"grant","acquired":true,"shares":7589,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $10,625 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $10,625 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan."}],"balance_after":41852,"source":{"system":"sec-edgar","filing":"0001179110-18-000448","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000117911018000448/edgar.xml","form_type":"4"}},{"id":4182901,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-19T20:29:40.000Z","date":"2017-10-12","kind":"purchase","acquired":true,"shares":565065,"price":8.6131,"value":4866961.3515,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reportable securities are owned directly by Longwood Fund II, LP, a Delaware limited partnership (\"Longwood II\").  Longwood Fund II GP, LLC, a Delaware limited liability company (\"Longwood II GP\"), is the general partner of Longwood II and exercises voting and investment power with respect to the securities owned directly by Longwood II.  Longwood II's investment adviser is Longwood Fund Management, LLC (\"Longwood Management\").  Each of the Reporting Person, who is a member of the Issuer's board of directors, and Christoph Westphal, M.D., Ph.D. (\"Westphal\") are the Managers (and are members) of Longwood II GP and may be deemed to share voting and investment power with respect to the securities owned by Longwood II."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"(Continue from footnote 1) Each of the Reporting Person, Westphal, Longwood II GP and Longwood Management disclaims beneficial ownership of the shares held by Longwood II and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":934484,"source":{"system":"sec-edgar","filing":"0000899243-17-024530","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000089924317024530/doc4.xml","form_type":"4"}},{"id":4194046,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-03T19:46:58.000Z","date":"2017-09-29","kind":"grant","acquired":true,"shares":7482,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan."}],"balance_after":34263,"source":{"system":"sec-edgar","filing":"0001179110-17-013052","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000117911017013052/edgar.xml","form_type":"4"}},{"id":4199035,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2017-09-29T19:13:58.000Z","date":"2017-09-27","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a 12 month period: 1/12th on October 27, 2017, after which 1/12th of the total shares vest monthly, subject to continued service through each vesting date."}],"balance_after":6000,"derivative":{"exercise_price":6.71,"expiration_date":"2027-09-26","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001140361-17-037012","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000114036117037012/doc1.xml","form_type":"4"}},{"id":4263698,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-05T19:11:30.000Z","date":"2017-06-30","kind":"grant","acquired":true,"shares":6810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan."}],"balance_after":26781,"source":{"system":"sec-edgar","filing":"0001179110-17-010098","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000117911017010098/edgar.xml","form_type":"4"}},{"id":4273343,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-23T20:57:03.000Z","date":"2017-06-21","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in twelve equal monthly installments at the end of each successive month following June 21, 2017."}],"balance_after":12000,"derivative":{"exercise_price":1.46,"expiration_date":"2027-06-21","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001179110-17-009556","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000117911017009556/edgar.xml","form_type":"4"}},{"id":4277218,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2017-06-19T07:34:16.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in equal quarterly installments over a one-year period, through and including June 15, 2018."}],"balance_after":10000,"derivative":{"exercise_price":13.29,"expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-040709","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000120919117040709/doc4.xml","form_type":"4"}},{"id":4360326,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-04T21:02:52.000Z","date":"2017-03-31","kind":"grant","acquired":true,"shares":5681,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan."}],"balance_after":19971,"source":{"system":"sec-edgar","filing":"0001179110-17-005742","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000117911017005742/edgar.xml","form_type":"4"}},{"id":4371412,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2017-03-27T19:04:03.000Z","date":"2017-03-23","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a 3 year period: 1/36th on December 21, 2016 after which 1/36th of the total shares vest monthly, subject to continued service through each vesting date."}],"balance_after":12000,"derivative":{"exercise_price":7.88,"expiration_date":"2027-03-22","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001140361-17-013496","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000114036117013496/doc1.xml","form_type":"4"}},{"id":4502068,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-04T20:29:03.000Z","date":"2015-06-30","kind":"gift","acquired":false,"shares":175481,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Richard H. Aldrich Irrevocable Trust of 2011"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"None of the transfers reported on this Form 4 constitutes a sale of the reported securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The trustee of the Richard H. Aldrich Irrevocable Trust of 2011 is the Reporting Person's spouse, Nichole Aldrich, and she exercises sole voting and investment power over the shares of record held by the trust."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-17-000417","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000117911017000417/edgar.xml","form_type":"4"}},{"id":4502067,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-04T20:29:03.000Z","date":"2015-06-30","kind":"gift","acquired":true,"shares":175481,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Little Eagles, LLC"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"None of the transfers reported on this Form 4 constitutes a sale of the reported securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Little Eagles, LLC. The owners of Little Eagles, LLC are Richard H. Aldrich Irrevocable Trust of 2011 and trusts established for the benefit of the Mr. Aldrich's minor children. The trustees of Richard H. Aldrich Irrevocable Trust of 2011 are Mr. Aldrich's spouse, Nichole A. Aldrich, and Mr. Aldrich's brother, Caleb F. Aldrich. The beneficiaries of Richard H. Aldrich Irrevocable Trust of 2011 are Mr. Aldrich's minor children. Mr. Aldrich disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":175481,"source":{"system":"sec-edgar","filing":"0001179110-17-000417","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000117911017000417/edgar.xml","form_type":"4"}},{"id":4502066,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-04T20:29:03.000Z","date":"2016-12-07","kind":"gift","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Richard H. Aldrich 2015 GRAT"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"None of the transfers reported on this Form 4 constitutes a sale of the reported securities."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-17-000417","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000117911017000417/edgar.xml","form_type":"4"}},{"id":4502065,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-04T20:29:03.000Z","date":"2016-12-07","kind":"gift","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"None of the transfers reported on this Form 4 constitutes a sale of the reported securities."}],"balance_after":807707,"source":{"system":"sec-edgar","filing":"0001179110-17-000417","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000117911017000417/edgar.xml","form_type":"4"}},{"id":4502064,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-04T20:29:03.000Z","date":"2016-12-13","kind":"gift","acquired":false,"shares":645842,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"None of the transfers reported on this Form 4 constitutes a sale of the reported securities."}],"balance_after":161865,"source":{"system":"sec-edgar","filing":"0001179110-17-000417","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000117911017000417/edgar.xml","form_type":"4"}},{"id":4502063,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-04T20:29:03.000Z","date":"2016-12-13","kind":"gift","acquired":true,"shares":645842,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Richard H. Aldrich 2005 Revocable Trust"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"None of the transfers reported on this Form 4 constitutes a sale of the reported securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The trustee of the Richard H. Aldrich 2005 Revocable Trust is the Reporting Person and he exercises sole voting and investment power over the shares of record held by the trust."}],"balance_after":668192,"source":{"system":"sec-edgar","filing":"0001179110-17-000417","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000117911017000417/edgar.xml","form_type":"4"}},{"id":4502062,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-04T20:29:03.000Z","date":"2016-12-22","kind":"gift","acquired":false,"shares":154519,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"None of the transfers reported on this Form 4 constitutes a sale of the reported securities."}],"balance_after":7346,"source":{"system":"sec-edgar","filing":"0001179110-17-000417","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000117911017000417/edgar.xml","form_type":"4"}},{"id":4502061,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-04T20:29:03.000Z","date":"2016-12-22","kind":"gift","acquired":true,"shares":154519,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Little Eagles, LLC"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"None of the transfers reported on this Form 4 constitutes a sale of the reported securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Little Eagles, LLC. The owners of Little Eagles, LLC are Richard H. Aldrich Irrevocable Trust of 2011 and trusts established for the benefit of the Mr. Aldrich's minor children. The trustees of Richard H. Aldrich Irrevocable Trust of 2011 are Mr. Aldrich's spouse, Nichole A. Aldrich, and Mr. Aldrich's brother, Caleb F. Aldrich. The beneficiaries of Richard H. Aldrich Irrevocable Trust of 2011 are Mr. Aldrich's minor children. Mr. Aldrich disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":330000,"source":{"system":"sec-edgar","filing":"0001179110-17-000417","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000117911017000417/edgar.xml","form_type":"4"}},{"id":4502060,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-04T20:29:03.000Z","date":"2016-12-30","kind":"grant","acquired":true,"shares":6944,"price":1.53,"value":10624.32,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"None of the transfers reported on this Form 4 constitutes a sale of the reported securities."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan."}],"balance_after":14290,"source":{"system":"sec-edgar","filing":"0001179110-17-000417","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000117911017000417/edgar.xml","form_type":"4"}},{"id":4540045,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-29T19:48:08.000Z","date":"2016-11-21","kind":"grant","acquired":true,"shares":369419,"ownership":{"direct":false,"nature":"By Longwood Fund II LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for 1,268,971 shares of KalVista Pharmaceuticals, Ltd. Series B Preferred Stock in connection with the closing of the share purchase transaction (the \"Transaction\") whereby KalVista Pharmaceuticals, Ltd. became a wholly-owned subsidiary of Carbylan Therapeutics, Inc., which changed its name to KalVista Pharmaceuticals, Inc. (the \"Company\"). On the effective date of the Transaction, the closing price of the Company's common stock was $9.38 per share. All numbers give effect to the 14:1 reverse stock split effected by the Company on November 21, 2016. Prior to the reverse stock split, the closing price of the Company's common stock was $0.67 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Longwood Fund II, LP, a Delaware limited partnership. Longwood Fund II GP, LLC (the \"Fund II General Partner\") is the general partner of Longwood Fund II, L.P. and exercises voting and investment power with respect to securities owned directly by Longwood Fund II, L.P. Longwood Fund II, L.P. is managed by Longwood Fund Management, LLC. Mr. Aldrich is a managing member of Longwood Fund Management LLC who disclaims beneficial ownership of the shares held by Longwood Fund II, L.P. except to the extent of his pecuniary interest therein."}],"balance_after":369419,"source":{"system":"sec-edgar","filing":"0001140361-16-088107","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000114036116088107/doc1.xml","form_type":"4"}},{"id":4586341,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":115912,"kind":"person","name":"ALDRICH RICHARD","position":1,"cik":"0001185039","reported_name":"ALDRICH RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-04T17:13:20.000Z","date":"2016-09-30","kind":"grant","acquired":true,"shares":1483,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan."}],"balance_after":607707,"source":{"system":"sec-edgar","filing":"0001179110-16-030320","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185039/000117911016030320/edgar.xml","form_type":"4"}}]}